Gain and loss of phosphorylation sites in human cancer

Bioinformatics

Volumn 24, Issue 16, 2008, Pages

  Radivojac, Predrag ^a   Baenziger, Peter H ^b   Kann, Maricel G ^c   Mort, Matthew E ^b   Hahn, Matthew W ^a,d   Mooney, Sean D ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE;

AMINO ACID SUBSTITUTION; BIOINFORMATICS; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC DATABASE; GENETIC DISORDER; HUMAN; MACHINE LEARNING; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID TUMOR; SOMATIC MUTATION;

EID: 49549115123     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btn267     Document Type: Conference Paper

References (37)

1. Alt,J.R. et al. (2000) Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev., 14, 3102-3114.
2. Benzeno,S. et al. (2006) Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene, 25, 6291-6303.
3. Bienz,M. and Clevers,H. (2000) Linking colorectal cancer to Wnt signaling. Cell, 103, 311-320.
4. Blume-Jensen,P. and Hunter,T. (2001) Oncogenic kinase signalling. Nature, 411, 355-365.
5. Boeckmann,B. et al. (2003) The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res., 31, 365-370.
6. Bromberg,Y. and Rost,B. (2007) SNAP: Predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res., 35, 3823-3835.
7. Care,M.A. et al. (2007) Deleterious SNP prediction: Be mindful of your training data! Bioinformatics, 23, 664-672.
8. Diehl,J.A. et al. (1998) Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev., 12, 3499-3511.
9. Diella,F. et al. (2004) Phospho.ELM: A database of experimentally verified phosphozylation sites in eukaryotic proteins. BMC Bioinformatics, 5, 79.
10. Futreal,P.A. et al. (2005) Somatic mutations in human cancer: insights from resequencing the protein kinase gene family. Cold Spring Harb Symp Quant Biol., 70, 43-49.
11. Garber,K. (2006) The second wave in kinase cancer drugs. Nat Biotech. 24, 127-130.
12. Goldman,N. and Yang,Z. (1994) A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol. Biol. Evol., 11, 725-736.
13. Greenman,C. et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature, 446, 153-158.
14. Hagen,T. and Vidal-Puig,A. (2002) Characterisation of the phosphorylation of [beta]-catenin at the GSK-3 priming site Scr45. Biochem. Biophys. Res. Commun., 294, 324-328.
15. Hubbard,T.J. et al. (2007) Ensembl 2007. Nucleic Acids Res., 35, D610-D617.
16. Iakoucheva,L.M., et al. (2004) The importance of intrinsic disorder for protein phosphorylation, Nucleic Acids Res., 32 1037-1049.
17. Kaminker,J.S. et al. (2007) CanPredict: A computational tool for predicting cancer-associated missense mutations. Nucleic Acids Res. 35, W595-W598.
18. Kaminker,J.S. et al. (2007) Distinguishing cancer-associated missense mutations from common polymorphisms. Cancer Res., 67 465-473.
19. Kryukov,G.V. et al. (2007) Most rare missense alleles are deleterious in humans: Implications for complex disease and association studies. Am. J. Hum. Genet., 80, 727-739.
20. Li,W.H. et al. (1985) A new method for estimating synonymous and nonsynonymous rates of nucleotide substitution considering the relative likelihood of nucleotide and codon changes. Mol. Biol. Evol., 2 150-174.
21. Lim,Y.P. (2005) Mining the tumor phosphoproteome for cancer markers. Clin. Cancer Res., 11, 3163-3169.
22. Moasser,M.M. (2007) Targeting the function of the HER2 oncogene in human cancer therapeutics. Oncogene, 26, 6577-6592.
23. Mori,Y. et al. (1992) Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene. Hum. Mol. Genet., 1, 229-233.
24. Ng,P.C. and Henikoff,S. (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res., 31, 3812-3814.
25. Obenauer,J.C. et al. (2003) Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res., 31, 3635-3641.
26. Ostedgaard,L.S. et al. (2007) Processing and function of CFTR-(Delta)F508 are species-dependent. Proc. Natl Acad. Sci. USA, 104, 15270-15375.
27. Ramensky,V. et al. (2002) Human non-synonymous SNPs server and survey. Nucleic Acids Res., 30, 3894-3900.
28. Rhesus Macaque Genome Sequencing and Analysis Consortium et al. (2007) Evolutionary and biomedical insights from the Rhesus Macaque genome. Science, 316, 222-234.
29. Schulze,W.X. et al. (2005) Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol. Syst. Biol., 1, 2005 0008, 1-13.
30. Shimizu,N. et al. (2007) MutationView/KMcancerDB: A database for cancer gene mutations. Cancer Sci., 98, 259-267.
31. Sjoblom,T. et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-274.
32. Spink,K.E. et al. (2000) Structural basis of the Axin-adenomatous polyposis coli interaction. EMBO J, 19, 2270-2279.
33. Stephens,B.J. et al. (2005) PRL phosphatases as potential molecular targets in cancer. Mol. Cancer Ther., 4, 1653-1661.
34. Vogt,G. et al. (2005) Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat. Genet., 37, 692-700.
35. Vogt,G. et al. (2007) Gain-of-glycosylation mutations. Curr. Opin. Genet. Dev., 17, 245-251.
36. Yarden,Y. and Sliwkowski,M.X. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol., 2, 127-137.
37. Yue,P. et al. (2006) SNPs3D: Candidate gene and SNP selection for association studies. BMC Bioinformatics, 7, 166.